Comments

scPharmaceuticals Stock Guidance

SCPHNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
Q4 2024 Earnings were released on Wed Mar 19th, after the market close
The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast
scPharmaceuticals (SCPH) ForecastNewsEarningsscPharmaceuticals (SCPH) Options

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

scPharmaceuticals Stock Guidance | NASDAQ:SCPH | Benzinga

scPharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
01/10/2025SCPH
scPharmaceuticals
FY2024———$36.20M$36.50M$36.33MGet Alert
01/10/2025SCPH
scPharmaceuticals
Q42024———$12.00M$12.30M$12.18MGet Alert
01/04/2024SCPH
scPharmaceuticals
FY2023———$13.40M$13.60M$12.82MGet Alert
01/04/2024SCPH
scPharmaceuticals
Q42023———$5.90M$6.10M$5.32MGet Alert

FAQ

Q

What is the most recent guidance for scPharmaceuticals (SCPH)?

A

There have been no specific sales or earnings guidance reported for scPharmaceuticals in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved